↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

150 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Abatacept  27件: Abatacept; Abatacept injection; Bms 188667 (abatacept); Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept (bms-188667); Abatacept (iv); Abatacept + csdmard; Abatacept + methotrexate; Abatacept + vaccines; Abatacept placebo; Abatacept prefilled syringe; Abatacept, rituximab or tocilizumab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Decrease tocilizumab, abatacept; Double-blind abatacept; Intravenous (iv) abatacept; Iv abatacept; Open-label abatacept; Orencia (abatacept); Orencia abatacept; Subcutaneous (sc) abatacept; Subcutaneous abatacept; Subcutaneous(sc) abatacept; Tocilizumab, abatacept; Abatacept subcutaneous; Abatacept sc; Abatacept (aba);   D03203   2件: CD80, CD86   3件: Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Rheumatoid arthritis   24件:
11,
13,
19,
41,
44,
46,
49,
50,
51,
53,
55,
60,
65,
84,
93,
96,
97,
107,
164,
222,
271,
284,
285,
300
 2   Abetimus  3件: Abetimus; Abetimus sodium; Abetimus sodium (ljp 394);   -   -   -   1件:
49
 3   Acetaminophen  8件: Acetaminophen; Acetaminophen tab 650mg; Acetaminophen/paracetamol; Acetaminophen tablets; Paracetamol (acetaminophen); Tramadol hydrochloride + acetaminophen; Oxycodone/acetaminophen; Tramadol /acetaminophen;   D00217   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   13件:
3,
6,
13,
34,
35,
46,
49,
51,
70,
86,
231,
256,
271
 4   Acetate  81件: Acetate; Leuprorelin acetate; 40 mg glatiramer acetate; Betamethasone sodium phosphate/betamethasone acetate (celestone® soluspan®), 30 mg im once a day for four days; Flecainide acetate; Oxaloacetate (oaa); Ulipristal acetate; 11c-acetate; 20mg/0.5ml glatiramer acetate; Bazedoxifene acetate; Cyclophosphamide/glatiramer acetate; Dirucotide acetate; Experimental glatiramer acetate; Glatiramer acetate; Glatiramer acetate (db); Glatiramer acetate (ga); Glatiramer acetate (ga) 40 mg; Glatiramer acetate (ol); Glatiramer acetate 150mg enteric coated tablets; Glatiramer acetate 150mg enteric-coated (gastro-resistant) tablets; Glatiramer acetate 20 mg; Glatiramer acetate 20 mg, with mitoxantrone; Glatiramer acetate 20 mg/0.5 ml; Glatiramer acetate 40 mg; Glatiramer acetate injection with oral cetirizine hydrochloride; Glatiramer acetate with minocycline; Glatiramer acetate, (copaxone®); Glatiramer acetate, ifn-beta 1a (im), ifn-beta 1a (subcutaneous), and ifn-beta 1b; Glatiramer acetate, n-acetylcysteine; Human interferon beta-1a and glatiramer acetate; Nomegestrol acetate; Plovamer acetate; Prednisone acetate; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); Sodium-[o-[(2,6-dichlorophenyl)-amino]-phenyl]-acetate; Tocopherol acetate; Depot leuprolide acetate 3.75 mg; Caspofungin acetate; Desmopressin acetate; Lanreotide acetate; Abiraterone acetate; Gonadorelin acetate and triptorelin acetate; Leuprolide acetate (la); Leuprolide acetate 11.25 mg; Leuprolide acetate 3 month depot; Leuprolide acetate 30 mg; Leuprolide acetate 45 mg; Leuprolide acetate depot; Leuprorelin acetate 3.75mg injection; Luphere depot 3.75mg(leuprolide acetate 3.75mg); Lupron (leuprolide acetate); Megestrol acetate; Megestrol acetate tablet; Triptorelin acetate and gonadorelin acetate; Macimorelin acetate; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Cortisone acetate; Hydrocortisone sodium acetate; Sodium acetate; Tetracosactide acetate; 11c acetate; Dichloroacetate; Dichloroacetate sodium; Zuretinol acetate; Etiprednol dicloacetate; Delmitide acetate; L-lysyl-d-prolyl-l-threonine acetate; Sotrastaurin (inn) acetate; Cosyntropin acetate; Tetracosactide hexaacetate; Glatiramer acetate (copaxone®); Zinc acetate; Zinc acetate dihydrate; Tocopheryl acetate; Prednisolone acetate; Prednisone acetate tablets; Desmopressin acetate trihydrate; Phosphate and betamethasone acetate, 2 ml.; [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate; Loestrin (norethindrone acetate and ethinyl estradiol); Zinc acetate (20mg/d);   -   -   -   40件:
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299
 5   Acetylcysteine  8件: Acetylcysteine; N-acetylcysteine; N-acetylcysteine capsule; Glatiramer acetate, n-acetylcysteine; N acetylcysteine; N-acetylcysteine (nac); N-acetylcysteine, (nac); Acetylcysteine sodium;   D00221   -   -   16件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
96,
97,
111,
164,
233,
298,
299
 6   Acetylsalicylic acid  2件: Acetylsalicylic acid; Acetylsalicylic acid at 1st visit,;   D00109   2件: PTGS1, PTGS2   1件: Arachidonic acid metabolism   10件:
13,
22,
34,
46,
49,
51,
86,
113,
158,
231
 7   Ademetionine  0件:   D07128   -   -   15件:
6,
14,
22,
43,
44,
46,
47,
49,
50,
60,
84,
93,
96,
97,
172
 8   Afamelanotide  1件: Afamelanotide;   D10511   -   -   2件:
49,
254
 9   Aldesleukin  3件: Aldesleukin; Low-dose aldesleukin (proleukin®); Interleukin-2 (aldesleukin).;   D00748   3件: IL2RA, IL2RB, IL2RG   3件: Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Pathways in cancer   4件:
2,
49,
65,
97
 10   Alemtuzumab  18件: Alemtuzumab; Alemtuzumab (gz402673); Alemtuzumab 12 mg; Alemtuzumab 24 mg; Alemtuzumab gz402673; Alemtuzumab immunotherapy; Alemtuzumab injection [lemtrada]; Alemtuzumab (campath); Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994; Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994); Alemtuzumab (campath ); Alemtuzumab and rituximab; Alemtuzumab, rituximab; Alemtuzumab 0.2 mg; Alemtuzumab 0.3 mg; Filgrastim, alemtuzumab; Transplant conditioning with mobilization and alemtuzumab; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan;   D02802   -   -   17件:
13,
15,
19,
20,
46,
49,
51,
60,
63,
65,
85,
96,
164,
234,
284,
285,
326
 11   Alfacalcidol  3件: Alendronate versus alfacalcidol (1-alpha oh vitamin d); Alfacalcidol; Ibandronate+alfacalcidol+calcium;   D01518   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   6件:
41,
46,
49,
50,
96,
235
 12   Alitretinoin  1件: Alitretinoin;   D02815   5件: RARA, RARB, RXRA, RXRB, RXRG   3件: PPAR signaling pathway, Pathways in cancer, Th17 cell differentiation   1件:
49
 13   Anakinra  8件: Anakinra; Anakinra (kineret®); Anakinra (r-methuil-1ra); Anakinra and peg stnf-r1; Kineret® (anakinra); Response to anakinra associated with methotrexate; Anakinra / kineret; Kineret® or anakinra;   D02934   2件: IL1R1, IL1R2   2件: Cytokine-cytokine receptor interaction, Inflammatory mediator regulation of TRP channels   17件:
2,
13,
15,
19,
37,
41,
46,
49,
50,
56,
65,
84,
86,
106,
107,
266,
299
 14   Anifrolumab  4件: Anifrolumab; Anifrolumab (medi-546); Anifrolumab 1000 mg; Anifrolumab 300 mg;   D11082   2件: IFNAR1, IFNAR2   1件: Cytokine-cytokine receptor interaction   2件:
46,
49
 15   Artenimol  0件:   D07362   -   -   1件:
49
 16   Ascorbic acid  4件: Ascorbic acid; Ascorbic acid (vitamin c); Ascorbic acid vit c; 2l polyethylene glycol/ascorbic acid;   D00018   -   -   13件:
10,
13,
49,
62,
86,
96,
97,
192,
206,
211,
212,
254,
284
 17   Atacicept  8件: Atacicept; Atacicept 150 mg; Atacicept 25 mg; Atacicept 75 mg; Atacicept 75 milligram (mg); Atacicept150mg; Atacicept25mg; Atacicept75mg;   D09704   2件: TNFSF13, TNFSF13B   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   4件:
13,
46,
49,
66
 18   Atorvastatin  9件: Atorvastatin; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Untreated to atorvastatin treatment; Atorvastatin tablet 20 mg; Atorvastatin 10mg; Atorvastatin 20mg; Lisinopril, losartan, and atorvastatin; Atorvastatin calcium;   D00258
 D00887
 D07474 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299
 19   Aviptadil  2件: Aviptadil; Aviptadil, 66 microgram/ml;   -   -   -   4件:
49,
51,
85,
86
 20   Azathioprine  33件: Azathioprine; Prednisone - azathioprine; Azathioprine (aza); Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Corticosteroid and azathioprine; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Azathioprine 25 mg; Continuation of azathioprine; Cyclophosphamide-prednisone-azathioprine; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Rituximab (rtx) and azathioprine (aza); Steroids plus azathioprine; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; Azathioprine (aza) or 6-mercaptopurine (6-mp); Azathioprine in case of endoscopic recurrence; Azathioprine individualised dose; Azathioprine or 6-mercaptopurine; Azathioprine or adalimumab and infliximab; Azathioprine or mesalazine; Azathioprine or methotrexate; Azathioprine weight-based dose; Azathioprine+enteral nutrition; Early immunosuppressants (azathioprine, methotrexate); Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, azathioprine; Azathioprine and allopurinol; Overencapsulated azathioprine (imuran) 50 mg tablet; Products containing azathioprine or 6-mercaptopurine; Azathioprine or mycophenolate mofetil;   D00238
 D03033 
 -   -   18件:
11,
13,
19,
35,
42,
43,
44,
45,
46,
49,
65,
66,
85,
94,
95,
96,
97,
162
 21   Baricitinib  3件: Baricitinib; Baricitinib, olumiant®; Tofacitinib/baricitinib;   D10308   2件: JAK1, JAK2   3件: Chemokine signaling pathway, JAK-STAT signaling pathway, Osteoclast differentiation   8件:
41,
46,
49,
50,
93,
107,
265,
325
 22   Belimumab  21件: Belimumab; Benlysta (belimumab); Benlysta® (belimumab); Belimumab 10 mg/kg; Belimumab 1 mg/kg; Belimumab 4 mg/kg; Belimumab 10 mg/kg plus standard therapy; Belimumab 100 mg sc; Belimumab 10mg/kg; Belimumab 200 mg sc; Belimumab 200 mg/ml; Belimumab for iv; Belimumab for sc; Belimumab injection; Belimumab or benlysta; Belimumab plus early vaccination; Belimumab plus late vaccination; Benlysta™ (belimumab); Sc belimumab 200 mg; Belimumab 10 mg; Gsk1550188 (belimumab);   D03068   1件: TNFSF13B   2件: Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway   8件:
11,
43,
44,
46,
49,
51,
53,
222
 23   Blisibimod  1件: Blisibimod;   D10311   -   -   5件:
43,
44,
49,
63,
66
 24   Bortezomib  6件: Bortezomib; Bortezomib/dexamethasone (bd), followed by autologous stc & maintenance bortezomib/dexamethasone; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Combination of a single dose anti-cd20 antibody and bortezomib; Bortezomib (velcade®);   D03150   1件: PSMB5   1件: Proteasome   13件:
11,
26,
28,
46,
49,
51,
61,
63,
66,
228,
256,
288,
331
 25   Brentuximab vedotin  1件: Brentuximab vedotin;   D09587   1件: TNFRSF8   1件: Cytokine-cytokine receptor interaction   2件:
49,
51
 26   Busulfan  13件: Busulfan; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Fludarabine/busulfan; Busulfan iv; Busulfan, cyclophosphamide, atg, gcsf; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Fludarabine, busulfan, thymoglobulin; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Campath, busulfan, clofarabine;   D00248   -   -   13件:
19,
20,
28,
36,
49,
51,
60,
65,
164,
274,
284,
285,
326
 27   CC-220  3件: Cc-220; Cc-220 0.3 mg daily; Cc-220 0.6mg daily;   -   -   -   2件:
49,
84
 28   Calcitriol  4件: Calcitriol; Delayed release 6mp or calcitriol vs. purinethol; Rapamycin-calcitriol combination; Calcitriol & calcium;   D00129   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   8件:
37,
46,
49,
66,
96,
158,
235,
326
 29   Calcium  26件: Calcium; Calcium carbonate; Calcium levofolinate; Ascal(r) / carbasalate calcium; Calcium and cholecalciferol; Calcium citrate; Carbasalate calcium; Ethylhydrogenfumarat, calciumsalz; Ibandronate+alfacalcidol+calcium; Rosuvastatin calcium; Calcium channel blockers; Calcium channel blockers (amlodipine, azelnidipine); Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Calcium citrate with vitamin d2; Vidofludimus calcium; Calcium gluconate; Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin); Low molecular weight heparin calcium injection; Amorphous calcium carbonate; Calcitriol & calcium; Calcium carbonate and alphacalcidol; Calcium lactate; Crystalline calcium supplements; Atorvastatin calcium; Calcium, dietary;   -   -   -   24件:
6,
13,
19,
46,
49,
51,
65,
68,
75,
79,
84,
93,
94,
95,
96,
97,
214,
215,
222,
224,
235,
265,
298,
299
 30   Cenerimod  5件: Cenerimod; Cenerimod 0.5 mg; Cenerimod 1 mg; Cenerimod 2 mg; Cenerimod 4 mg;   D11283   1件: S1PR1   2件: Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway   1件:
49
 31   Chloroquine  14件: Chloroquine; Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Chloroquine diphosphate; Chloroquine diphosphate 250mg;   D02125
 D02366
 D03469 
 -   -   4件:
46,
49,
95,
130
 32   Cholecalciferol  9件: Cholecalciferol; Cholecalciferol, vitamin d3; Calcium and cholecalciferol; Cholecalciferol and c. xanthorrhiza; Cholecalciferol 10,000 iu; Cholecalciferol 400 iu; Cholecalciferol concentrate; 5000 iu of cholecalciferol; Cholecalciferol (vitamin d3);   D00188   1件: VDR   2件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption   15件:
6,
13,
19,
20,
34,
46,
49,
53,
60,
65,
96,
97,
228,
298,
299
 33   Ciclosporin  7件: Ciclosporin; Ciclosporina; Ciclosporine; Aerolised liposomal ciclosporin a; Ciclosporin (ciclosporinium); Ciclosporin a; Ciclosporine, ciclosporina;   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   44件:
11,
14,
19,
20,
26,
28,
36,
38,
39,
40,
41,
42,
45,
46,
49,
50,
53,
55,
56,
58,
60,
61,
62,
63,
64,
65,
90,
95,
97,
113,
162,
164,
222,
223,
226,
228,
234,
269,
274,
283,
284,
285,
302,
326
 34   Clofarabine  2件: Clofarabine; Campath, busulfan, clofarabine;   D03546   3件: POLA1, POLA2, RRM1   3件: DNA replication, Purine metabolism, Pyrimidine metabolism   9件:
19,
20,
40,
46,
49,
60,
96,
234,
326
 35   Clopidogrel  1件: Clopidogrel;   D00769
 D07729
 D10823
 D10824 
 -   -   2件:
49,
86
 36   Coenzyme M  0件:   -   -   -   9件:
13,
44,
45,
49,
51,
60,
65,
96,
164
 37   Conjugated estrogens  0件:   D04070
 D05987 
 -   -   1件:
49
 38   Corticotropin  10件: Corticotropin; Repository corticotropin injection; H.p. acthar gel (repository corticotropin injection); H.p. acthar® gel (repository corticotropin injection); Corticotropin-releasing hormone; Ovine corticotropin-releasing hormone (ocrh); Corticotropin releasing hormone; Repository corticotropin injection -treatment extension; Adrenocorticotropin; Adrenocorticotropin hormone;   D00146   1件: MC2R   3件: Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Neuroactive ligand-receptor interaction   12件:
2,
13,
46,
49,
50,
66,
75,
78,
84,
145,
193,
222
 39   Creatine  4件: Creatine; Creatine monohydrate; Pyruvate, creatine, niacinamide; Creatine-13c;   -   -   -   12件:
1,
2,
5,
6,
8,
13,
46,
49,
50,
113,
156,
201
 40   Curcumin  6件: Curcumin; Ifn beta 1 a + curcumin (bcm 95); Nanocurcumin; Curcumin (longvida™); Curcumin supplement; Bio-enhanced curcumin soft gelatin capsule;   -   -   -   10件:
13,
46,
49,
67,
74,
94,
96,
97,
139,
299
 41   Cyanocobalamin  0件:   D00166
 D03615
 D03616
 D03617 
 -   -   12件:
6,
13,
49,
62,
86,
96,
97,
201,
229,
254,
284,
299
 42   Cyclophosphamide  49件: Cyclophosphamide; Cyclophosphamide (drug); Cyclophosphamide and atg; Cyclophosphamide monohydrate; Cyclophosphamide/glatiramer acetate; Busulfan, cyclophosphamide, antithymocyte globulin; Busulfan, cyclophosphamide, atg; Cyclophosphamide, bortezomib, dexamethasone; Cyclophosphamide, bortezomib, dexamethasone plus daratumumab; Lenalidomide, dexamethasone and cyclophosphamide; Rituximab and cyclophosphamide iv; Prednisone, cyclophosphamide; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Cyclophosphamide-prednisone-azathioprine; Iv cyclophosphamide; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Cyclophosphamide (cy); Cyclophosphamide (cy) (plan 1); Cyclophosphamide (cy) (plan 2); Cyclophosphamide 100mg; Cyclophosphamide 150mg; Cyclophosphamide 50mg; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Cyclophosphamide,campath ih and tbi; Cyclophosphamide,cyclosporine a; Fludarabine, cyclophosphamide; Haploidentical hsct using tbi free regimen, ''atg'' with ''post transplant cyclophosphamide''; Busulfan, cyclophosphamide, atg, gcsf; Campath, fludarabine, cyclophosphamide; Cyclophosphamide 30; Cyclophosphamide 40; Cyclophosphamide dose level 1; Cyclophosphamide dose level 2; Cyclophosphamide dose level 3; Cyclophosphamide dose level 4; Cyclophosphamide post transplant; Prednisone and cyclophosphamide; Prednisone plus cyclophosphamide; High-dose cyclophosphamide; Cyclophosphamide 50mg oral tablet; Cyclophosphamide and steroids; Cyclophosphamide(ctx); Cyclophosphamide + pred; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen); Thalidomide, cyclophosphamide and prednisone;   D00287
 D07760 
 -   -   43件:
13,
14,
16,
19,
20,
26,
28,
35,
36,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
52,
56,
60,
61,
62,
65,
66,
84,
85,
93,
96,
162,
164,
172,
222,
224,
265,
274,
283,
284,
285,
288,
326,
331
 43   Cytarabine  2件: Cytarabine; Carmustine, etoposide, cytarabine, and melphalan (beam);   D00168
 D03046
 D03637 
 -   -   6件:
11,
13,
14,
25,
49,
60
 44   D-glucose  3件: 2-deoxy-2 [f-18] fluoro-2-d-glucose; D-glucose; [18f]fluoro-2-deoxy-2-d-glucose;   D00009   -   -   6件:
6,
13,
49,
86,
88,
299
 45   Dapagliflozin  1件: Dapagliflozin;   D08897   -   -   2件:
49,
222
 46   Dimethyl fumarate  4件: Dimethyl fumarate; Dimethyl fumarate (dmf); Dimethyl fumarate [dmf]; Tecifdera (dimethyl fumarate);   D03846   -   -   5件:
13,
46,
49,
51,
86
 47   Diphenhydramine  1件: Diphenhydramine;   D00300
 D00669
 D02419
 D03285
 D03360
 D03854 
 1件: HRH1   2件: Calcium signaling pathway, Neuroactive ligand-receptor interaction   5件:
49,
51,
70,
86,
256
 48   Dipyridamole  7件: Amoxapine & dipyridamole; Dipyridamole; Prednisolone & dipyridamole; Prednisolone-dipyridamole; Z102 (prednisolone and dipyridamole).; Extended release dipyridamole 200mg/aspirin 25mg; Dipyridamole tab 25 mg;   D00302   2件: PDE4A, PDE5A   2件: cAMP signaling pathway, cGMP-PKG signaling pathway   5件:
46,
49,
51,
66,
224
 49   Doconexent  0件:   -   -   -   7件:
6,
49,
90,
94,
240,
299,
301
 50   Duloxetine  3件: Duloxetine; Duloxetine hydrochloride; Duloxetine hydrochloride (hci);   D01179
 D07880 
 2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   3件:
6,
13,
49
 51   Edratide  1件: Edratide;   D03957   -   -   1件:
49
 52   Efalizumab  1件: Efalizumab;   D03959   1件: ITGAL   2件: Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity   9件:
11,
13,
37,
46,
49,
53,
61,
95,
96
 53   Epratuzumab  8件: Epratuzumab; Epratuzumab 100 mg; Epratuzumab 1200 mg; Epratuzumab 400 mg; Epratuzumab 600 mg; Epratuzumab iv; Epratuzumab sc; Hll2 (epratuzumab);   D04036   1件: CD22   3件: B cell receptor signaling pathway, Cell adhesion molecules (CAMs), Hematopoietic cell lineage   1件:
49
 54   Estradiol  9件: Estradiol; Estradiol hemihydrate; Ethinylestradiol; Ethinyl estradiol; Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol); 5% lidocaine/5 mg/ml estradiol compound cream; Estradiol 2 mg; Loestrin (norethindrone acetate and ethinyl estradiol); Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg;   D00105
 D01413
 D01617
 D01953
 D04061
 D04063
 D04064
 D04065 
 2件: ESR1, ESR2   2件: Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway   5件:
13,
46,
49,
226,
299
 55   Ethanol  14件: Endocannabinoid palmitoylethanolamide (pea); Palmitoylethanolamide; Treprostinil diethanolamine; Ut-15c (treprostinil diethanolamine); Ut-15c sr (treprostinil diethanolamine); Andrographis paniculata (ethanol extract); Ethanol; Ethanol (96 per cent); Ethanol 96% gel; Ethanol 98% solution; Ethanol bp; Ethanol gel; Ethanolamine; Ethanolamine oleate;   D00068
 D02798
 D04855
 D06542 
 -   -   49件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
58,
61,
63,
64,
65,
66,
81,
84,
85,
86,
88,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
279,
280,
283,
284,
285,
288,
298,
299,
300,
331
 56   Ethinylestradiol  1件: Ethinylestradiol;   D00554   1件: ESR1   3件: Breast cancer, Estrogen signaling pathway, Pathways in cancer   4件:
13,
46,
49,
299
 57   Evobrutinib  2件: Evobrutinib; M2951 (other name: evobrutinib);   -   -   -   3件:
13,
46,
49
 58   Ezetimibe  5件: Ezetimibe; Ezetimibe+simvastatin drug combination; Comparator: ezetimibe; Ezetimibe + other lipid-lowering medication(s); Mk0653, ezetimibe;   D01966   1件: NPC1L1   1件: Fat digestion and absorption   4件:
49,
79,
93,
260
 59   Filgrastim  7件: Filgrastim; Pegfilgrastim; Ep2006 (filgrastim); Filgrastim hexal; Filgrastim, alemtuzumab; Granulocyte colony-stimulating factor (filgrastim); Filgrastim (g-csf);   D03235   1件: CSF3R   5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer   28件:
2,
6,
13,
16,
25,
26,
28,
34,
35,
36,
40,
41,
42,
45,
46,
49,
51,
60,
62,
65,
85,
96,
113,
164,
283,
284,
285,
331
 60   Fish oil  10件: Fish oil; Fish oil concentrate; Fish oil, rich in omega-3-acids; Fish oil,rich in omega 3 acids; Lipoic acid (la) with fish oil and la without fish oil; Combination fish oil and borage seed oil; Fish oil supplement; Fish oil, gamma-linolenic acid; Omega-3 fatty acid fish oil supplement; Combination of fish oil and colesevelam;   -   -   -   7件:
13,
46,
49,
66,
96,
260,
299
 61   Fludarabine  23件: Fludarabine; Fludarabine phosphate; Fludarabine monophosphate; Sq fludarabine; Busulfan, fludarabine, & cyclophosphamide with immunosuppression with atg and cyclosporine.; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Cyclophosphamide, fludarabine , thymoglobulin; Cyclophosphamide, fludarabine, rabbit atg; Cyclophosphamide, fludarabine, thymoglobulin; Fludarabine (flu); Fludarabine, cyclophosphamide; Fludarabine/ melphalan; Fludarabine/busulfan; Busulfan, fludarabine and atg; Busulfan, fludarabine, atg, tli; Campath, fludarabine, cyclophosphamide; Fludarabine phosphate 30 mg; Fludarabine phosphate 40 mg; Fludarabine, busulfan, thymoglobulin; Fludarabine, melphalan, thiotepa; Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan; Cyclophosphamide, fludarabine; Busulfan, cyclophosphamide, thymoglobulin, fludarabine (conditioning regimen);   D01907
 D07966 
 1件: RRM1   2件: Purine metabolism, Pyrimidine metabolism   17件:
13,
28,
36,
46,
49,
51,
60,
61,
62,
65,
85,
96,
164,
283,
284,
285,
326
 62   Fluorine F-18  0件:   D05860   -   -   4件:
40,
46,
49,
96
 63   Folic acid  5件: Folic acid; Folic acid, vitamin b6, vitamin b12; Folic acid or folate; Rituximab, mtx, folic acid; Methotrexate and folic acid;   D00070   -   -   11件:
6,
13,
46,
49,
62,
84,
86,
96,
97,
254,
284
 64   Forigerimod  1件: Forigerimod;   D09904   -   -   1件:
49
 65   Fostamatinib  9件: Fostamatinib; Fostamatinib 50 mg blue film-coated tablet; Fostamatinib disodium; Fostamatinib disodium (r935788); Fostamatinib 150 mg bid; Fostamatinib 100 mg; Fostamatinib 150 mg; Fostamatinib disodium tablet 100 mg; Fostamatinib disodium tablet 150 mg;   D09347   1件: SYK   2件: B cell receptor signaling pathway, NF-kappa B signaling pathway   4件:
46,
49,
61,
66
 66   Green olive  0件:   -   -   -   3件:
13,
49,
53
 67   Human interleukin-2  3件: Human interleukin-2; Recombinant human interleukin-2 (rhil-2); Anti-human interleukin-23 monoclonal antibody;   -   -   -   14件:
2,
13,
35,
46,
49,
51,
55,
56,
63,
65,
95,
96,
97,
271
 68   Human papillomavirus type 11 L1 capsid protein antigen  0件:   -   -   -   1件:
49
 69   Human papillomavirus type 16 L1 capsid protein antigen  0件:   -   -   -   1件:
49
 70   Human papillomavirus type 18 L1 capsid protein antigen  0件:   -   -   -   1件:
49
 71   Human papillomavirus type 6 L1 capsid protein antigen  0件:   -   -   -   1件:
49
 72   Hydroxychloroquine  16件: Hydroxychloroquine; Hydroxychloroquine sulfate; Leflunomide-sulfasalazine-hydroxychloroquine; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate-sulfasalazine-hydroxychloroquine; Sulphasalazine + hydroxychloroquine or prednisolone; Hydroxychloroquine (z0188); Hydroxychloroquine high; Hydroxychloroquine or chloroquine; Hydroxychloroquine reduced; Versus hydroxychloroquine; Hydroxychloroquine + prednisone; Sirolimus and hydroxychloroquine; Hydroxychloroquine higher dose; Hydroxychloroquine lower dose; Hydroxychloroquine sulphate;   D08050   -   -   18件:
13,
41,
46,
48,
49,
53,
56,
66,
84,
89,
90,
96,
222,
234,
254,
271,
298,
299
 73   Ibandronate  2件: Ibandronate; Ibandronate+alfacalcidol+calcium;   D08056   1件: FDPS   1件: Terpenoid backbone biosynthesis   2件:
46,
49
 74   Icosapent  1件: Eicosapentaenoic acid;   D08061   -   -   5件:
49,
96,
97,
296,
297
 75   Immune Globulin Human  0件:   -   -   -   20件:
2,
11,
13,
14,
17,
18,
35,
38,
39,
43,
45,
49,
50,
51,
63,
65,
85,
164,
296,
309
 76   Infliximab  66件: Infliximab; Infliximab [infliximab biosimilar 3]; Topical infliximab; Remicaide (infliximab); Abp 710 - biosimilar to infliximab; Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar infliximab; Infliximab (inf) + mtx, db; Infliximab (remicade); Infliximab + methotrexate (mtx); Infliximab 10 mg/kg; Infliximab 3 mg/kg; Infliximab biosimilar; Infliximab control; Infliximab group; Infliximab increased dose; Infliximab increased frequency; Infliximab, etanercept; Infliximab, etanercept, adalimumab; Infliximab, methylprednisolone, methotrexate; Infliximab-eu; Infliximab-pfizer; Innovator infliximab; Methotrexate + infliximab; Remicade (infliximab); Remicade® (infliximab); Remsima (infliximab); Response to infliximab associated with methotrexate; Sb2 (infliximab biosimilar); Sb2 (proposed biosimilar to infliximab); Ta-650 (infliximab); Tnf blockers (infliximab, adalimumab, etanercept); Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Intravitreal infliximab; 99m technetium infliximab; 99mtc-infliximab; Inflectra (infliximab); Adalimumab and infliximab; Anti tnf therapy including infliximab; Anti-tnf: infliximab (infusion); Azathioprine or adalimumab and infliximab; Ct-p13 sc (infliximab); Infliximab (ifx alone); Infliximab (remicade): 100 mg of lyophilized infliximab; Infliximab 20 mg/kg; Infliximab 5 mg/kg; Infliximab 5 mg/kg body weight infused over 2 hours; Infliximab 5 mg/kg every 6 weeks; Infliximab 7 mg/kg every 8 weeks; Infliximab and adalimumab; Infliximab and azathioprine combination at week 0; Infliximab and azathioprine combination at week 14; Infliximab infusion; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab with azathioprine (iifx + aza); Infliximab+azathioprine; Infliximab, adalimumab, certolizumab pegol; Infliximab, azathioprine; Infliximab-biosimilar; Infliximab-innovator; Cyclosporine vs infliximab; Infliximab (ifx); Adalimumab, etanercept, golimumab or infliximab; Infliximab (bcd-055); Infliximab and mtx;   D02598   1件: TNF   9件: Adipocytokine signaling pathway, Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   23件:
35,
37,
38,
39,
40,
41,
43,
45,
46,
49,
50,
56,
65,
84,
85,
95,
96,
97,
98,
162,
164,
269,
271
 77   Iscalimab  1件: Iscalimab;   D11610   1件: CD40   4件: Allograft rejection, Cell adhesion molecules (CAMs), Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway   1件:
49
 78   Laquinimod  8件: Laquinimod; Laquinimod 0.6; Laquinimod 1.2; Laquinimod capsules 0.3 mg; Laquinimod capsules 0.6 mg; Laquinimod sodium (usan); Laquinimod tablets 0.3 mg; Laquinimod cápsulas 0.5 mg;   -   -   -   4件:
8,
13,
49,
96
 79   Leflunomide  10件: Leflunomide; Leflunomide 10mg tab; Leflunomide (permitted, not necessary); Leflunomide 20 mg tablets (geneva pharmaceutical); Leflunomide 20mg tab; Leflunomide-sulfasalazine-hydroxychloroquine; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Leflunomide mylan; Leflunomide 20 mg+prednisone 0.5mg/kg/d; Leflunomide(lef);   D00749   1件: DHODH   1件: Pyrimidine metabolism   10件:
11,
40,
46,
49,
53,
66,
162,
224,
271,
300
 80   Lenalidomide  5件: Lenalidomide; Lenalidomide and dexamethasone; Lenalidomide+dexamethasone; Lenalidomide, dexamethasone; Lenalidomide, dexamethasone and cyclophosphamide;   D04687   1件: TNF   6件: Apoptosis, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, TNF signaling pathway   8件:
16,
26,
28,
34,
49,
96,
284,
300
 81   Levosalbutamol  0件:   D08124   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   1件:
49
 82   Levothyroxine  1件: Levothyroxine;   D01010
 D08125 
 2件: THRA, THRB   2件: Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway   2件:
49,
78
 83   Lulizumab pegol  1件: Lulizumab pegol;   -   -   -   2件:
49,
53
 84   Melatonin  10件: Melatonin; Melatonin pr; Melatonin(circadin®); 3 mg melatonin; 5 mg melatonin; Circadin ( inn= melatonin); Diazepam, melatonin; Dtr melatonin (nih cc pds); Hourly dosing of the nychtemeral secretion of melatonin; Melatonin cr;   D08170   2件: MTNR1A, MTNR1B   2件: Circadian entrainment, Neuroactive ligand-receptor interaction   8件:
6,
13,
46,
49,
90,
97,
144,
202
 85   Meloxicam  9件: Meloxicam; Meloxicam 0.125 mg/kg; Meloxicam 0.25 mg/kg; Meloxicam ampoule; Meloxicam cf tablet 7,5mg; Meloxicam oral suspension; Meloxicam tablet; Aspirin and meloxicam; Meloxicam suppository;   D00969   1件: PTGS2   1件: Arachidonic acid metabolism   4件:
46,
49,
271,
296
 86   Memantine  3件: Memantine; Memantine (ebixa); Memantine hydrochloride;   D04905
 D08174 
 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D   3件: Alzheimer disease, Glutamatergic synapse, Neuroactive ligand-receptor interaction   7件:
2,
6,
8,
13,
49,
127,
205
 87   Metformin  15件: Metformin; Glucophage (metformin); Metformin/cp-690,550; Metformin hydrochloride; Metformine; Metformine sandoz 850 mg filmomhulde tabletten; 750 mg metformin and 7.5 g l-citrulline daily p.o.; L-citrulline and metformin & l-citrulline; Metformin 500mg; Metformin and metformin & l-citrulline; Metformin (generic); Sitagliptin and metformin; Pioglitazone or metformin; Metformin hcl; Metformine hcl 500 pch;   D00944
 D04966 
 2件: PRKAA1, PRKAA2   3件: AMPK signaling pathway, Adipocytokine signaling pathway, Insulin signaling pathway   17件:
6,
13,
46,
49,
67,
75,
77,
81,
86,
113,
158,
206,
225,
233,
265,
285,
299
 88   Methamidophos  0件:   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300
 89   Methotrexate  81件: Methotrexate; Intrathecal methotrexate; Methotrexate treatment; Mycophenolate mofetil,methotrexate; Methotrexate 2.5 mg; Methotrexate 25 mg; Abatacept (aba) + methotrexate (mtx), double-blind (db); Abatacept + methotrexate; Adalimumab with methotrexate; Bms-582949 and methotrexate; Certolizumab pegol + methotrexate (mtx); Cp-690,550 + methotrexate; Etanercept + methotrexate; Etanercept , methotrexate; Infliximab + methotrexate (mtx); Infliximab, methylprednisolone, methotrexate; Methotrexate 'lederle' 2,5mg tablets; Methotrexate 'lederle' 2.5mg tablets; Methotrexate (metoject® prefilled pen); Methotrexate (mtx); Methotrexate + biologic administration; Methotrexate + infliximab; Methotrexate + methylprednisolone; Methotrexate + salazopyrine + hydroxychloroquine administration; Methotrexate - amneal; Methotrexate - dava; Methotrexate - delay; Methotrexate - etanercept - prednisolone arm; Methotrexate - immediate; Methotrexate 2.5 mg tablets; Methotrexate 2.5mg tablets; Methotrexate 2.5mg tablets bp; Methotrexate 50mg/ml solution for injection, pre-filled syringe; Methotrexate as methotrexate disodium; Methotrexate capsules; Methotrexate disodium; Methotrexate pfizer 2,5 mg tabletter; Methotrexate placebo; Methotrexate plus enbrel or enbrel alone; Methotrexate plus erb-041 for 12 weeks; Methotrexate plus sulfasalazine; Methotrexate pre-filled pen; Methotrexate prefilled pen; Methotrexate prefilled syringe; Methotrexate sodium; Methotrexate sodium 2.5mg tablets; Methotrexate sodium tablets 2.5 mg; Methotrexate(mtx); Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol.; Methotrexate(necessary); Methotrexate*100cpr 2,5mg; Methotrexate, leucovorin and bms-986142; Methotrexate,adalimumab; Methotrexate-lachema; Methotrexate-sulfasalazine-hydroxychloroquine; Methotrexate® 2.5 mg tablets; Mp-435(dose1) + methotrexate; Oral methotrexate; Phase 1: methotrexate; Response to anakinra associated with methotrexate; Response to infliximab associated with methotrexate; Stable weekly dose of methotrexate; Tacrolimus with methotrexate; Tasocitinib plus methotrexate; Tocilizumab + methotrexate(mtx); Tocilizumab+methotrexate(mtx); Tofacitinib with methotrexate; Tofacitinib without methotrexate; Urine samples taken to measure methotrexate and its major metabolite 7-oh-methotrexate level; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Methotrexate and folic acid; Methotrexate lachema 5inj. sol; Etanercept, methotrexate, prednisolone; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Azathioprine or methotrexate; Early immunosuppressants (azathioprine, methotrexate); Methotrexate bellon; Methotrexate bellon 25mg/ml; Clobetasol propionate + methotrexate; Treatment with systemic therapy (methotrexate); Cyclosporin, methotrexate (gvhd prophylaxis);   D00142
 D02115 
 2件: DHFR, DHFR2   2件: Folate biosynthesis, One carbon pool by folate   33件:
11,
13,
19,
34,
35,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
55,
56,
60,
62,
65,
84,
93,
96,
97,
162,
164,
172,
256,
271,
284,
285,
326,
331
 90   Methylprednisolone  29件: Methylprednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Infliximab, methylprednisolone, methotrexate; Methotrexate + methylprednisolone; Administration of rituximab and methylprednisolone; Methylprednisolone (mp); Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Intravenous methylprednisolone; Intravenous (i.v.) methylprednisolone 1000 mg, total 9;   D00407
 D00751
 D00979
 D05000
 D05001
 D05002 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   36件:
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296
 91   Milatuzumab  1件: Milatuzumab;   D08944   -   -   1件:
49
 92   Milnacipran  1件: Milnacipran;   D08222   2件: SLC6A2, SLC6A4   2件: Serotonergic synapse, Synaptic vesicle cycle   2件:
46,
49
 93   Mizoribine  1件: Mizoribine;   D01392   2件: IMPDH1, IMPDH2   2件: Metabolic pathways, Purine metabolism   8件:
46,
49,
51,
53,
66,
94,
222,
224
 94   Modafinil  5件: Armodafinil; Modafinil; Modafinil 50mg; Over-encapsulated modafinil; Provigil (modafinil);   D01832   -   -   4件:
6,
13,
49,
93
 95   Moxifloxacin  6件: Moxifloxacin; Moxifloxacin infusion; Moxifloxacina cloridrato; Avelox- moxifloxacin; Moxifloxacin 400 mg; Moxifloxacin hydrochloride;   D00874
 D08237 
 -   -   8件:
2,
6,
46,
49,
85,
86,
240,
299
 96   Mycophenolate mofetil  17件: Mycophenolate mofetil; Mycophenolate mofetil (cellcept); Mycophenolate mofetil [cellcept]; Mycophenolate mofetil (mmf) 3 g/day; Mycophenolate mofetil 2 g/day; Cellcept (mycophenolate mofetil); Mycophenolate mofetil,methotrexate; Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate); Mycophenolate mofetil (mmf); Mycophenolate mofetil plus lower dose of prednisone; Azathioprine or mycophenolate mofetil; Mycophenolate mofetil orally 1000 mg twice a day (bid); Mycophenolate mofetil, low dose steroid; Prednisolone and mycophenolate mofetil; Mycophenolate mofetil(mmf); Cyclosporine combine with mycophenolate mofetil; Prednisone and mycophenolate mofetil;   D00752
 D05094
 D05095 
 2件: IMPDH1, IMPDH2   1件: Purine metabolism   32件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
85,
95,
96,
162,
164,
222,
224,
226,
234,
283,
284,
285,
300
 97   Mycophenolic acid  2件: Mycophenolic acid; Mycophenolic acid mofetil;   D05096   2件: IMPDH1, IMPDH2   1件: Purine metabolism   34件:
2,
11,
13,
14,
19,
20,
28,
35,
36,
42,
43,
45,
49,
51,
53,
60,
62,
65,
66,
84,
85,
95,
96,
162,
164,
222,
224,
226,
228,
234,
283,
284,
285,
300
 98   Nelfinavir  2件: Nelfinavir; Nelfinavir mesylate;   D00899
 D08259 
 -   -   3件:
49,
265,
331
 99   Nicotinamide  2件: Nicotinamide; Nicotinamide riboside;   D00036   -   -   8件:
5,
6,
13,
46,
49,
53,
67,
162
 100   Nivolumab  1件: Nivolumab;   D10316   1件: PDCD1   3件: Cell adhesion molecules (CAMs), PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway   10件:
13,
26,
41,
46,
49,
50,
51,
53,
96,
97
 101   Norethisterone  0件:   D00182
 D00953 
 1件: PGR   3件: Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation   4件:
13,
46,
49,
299
 102   Ocrelizumab  12件: Ocrelizumab; Ocrelizumab 300 mg; Ocrelizumab 300mg; Ocrelizumab 300mg /10ml; Ocrelizumab 300mg/10ml; Ocrelizumab 600 mg; Ocrelizumab dose 1; Ocrelizumab dose 2 and dose 3; Ocrelizumab / rhumab 2h7; Ocrelizumab 500mg; Ocrelizumabu 200mg; Ocrelizumabu 50mg;   D05218   1件: MS4A1   1件: Hematopoietic cell lineage   3件:
13,
46,
49
 103   Olea europaea leaf  0件:   -   -   -   3件:
13,
49,
53
 104   Olive oil  2件: Freshly-pressed extra virgin olive oil; Olive oil;   D03311   -   -   4件:
13,
49,
53,
96
 105   Omega-3 fatty acids  3件: Lipoic acid and omega-3 fatty acids; Omega-3 fatty acids; Triomar™ (omega-3 fatty acids);   -   -   -   7件:
13,
46,
49,
66,
79,
96,
299
 106   Omega-3-acid ethyl esters  0件:   D05255   2件: CETP, LPL   3件: Cholesterol metabolism, Glycerolipid metabolism, PPAR signaling pathway   1件:
49
 107   Oxygen  10件: Oxygen; Oxygen 40 %; Nitric oxide plus oxygen; Oxygen supplementation; Continuous oxygen; Medical air vs oxygen; Maternal hyperoxygenation; Medical grade oxygen; Perfluorinated gas/oxygen mixture; Helium / oxygen mixed gas inhalation therapy;   D00003   -   -   18件:
5,
6,
17,
46,
49,
70,
84,
85,
86,
88,
90,
96,
97,
193,
211,
226,
299,
330
 108   Ozone  1件: Ozone;   -   -   -   2件:
49,
51
 109   PF-06700841  4件: Pf-06700841; Pf-06700841 15 mg; Pf-06700841 30 mg; Pf-06700841 45 mg;   -   -   -   3件:
49,
96,
97
 110   Paquinimod  1件: Paquinimod;   -   -   -   2件:
49,
51
 111   Phosphate ion  0件:   -   -   -   29件:
2,
3,
11,
12,
13,
28,
36,
46,
49,
51,
53,
60,
62,
65,
70,
78,
81,
83,
90,
96,
97,
164,
235,
256,
283,
284,
285,
286,
299
 112   Pioglitazone  6件: Pioglitazone; Pioglitazone and tretinoin; Tretinoin and pioglitazone hcl; Actos (pioglitazone); Pioglitazone 15 mg; Pioglitazone or metformin;   D00945
 D08378 
 1件: PPARG   2件: AMPK signaling pathway, PPAR signaling pathway   17件:
2,
6,
13,
15,
20,
46,
49,
65,
67,
78,
81,
86,
96,
229,
265,
298,
299
 113   Pitavastatin  1件: Pitavastatin;   D01862   -   -   1件:
49
 114   Prasterone  2件: Prasterone; Prasterone (gl701);   D08409   2件: ESR1, ESR2   1件: Estrogen signaling pathway   6件:
49,
53,
83,
86,
96,
113
 115   Pravastatin  4件: Pravastatin; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; Pravastatin sodium; Lonafarnib, zoledronic acid, and pravastatin;   D00893
 D08410 
 1件: HMGCR   2件: Bile secretion, Terpenoid backbone biosynthesis   9件:
13,
46,
49,
67,
79,
96,
164,
265,
333
 116   Prednisolone  74件: Prednisolone; Iv methylprednisolone; Iv methylprednisolone (steroids); Megadose oral methylprednisolone; Methyloprednisolone; Methylprednisolone; Methylprednisolone (drug); Methylprednisolone hemisuccinate; Methylprednisolone iv; Methylprednisolone sodium hemisuccinate; Methylprednisolone sodium succinate; Peg-liposomal prednisolone sodium phosphate; Prednisolone sodium phosphate; Prednisone/prednisolone; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Intravenous methyl prednisolone; Methyl prednisolone; Methylprednisolone (or other glucocorticoid); Prednisone (and methylprednisolone); Prednisone, methylprednisolone,cyclophosphamides; Infliximab, methylprednisolone, methotrexate; Long-circulating liposomal prednisolone; Methotrexate + methylprednisolone; Methotrexate - etanercept - prednisolone arm; Overencapsulated prednisolone tablets; Paroxetine & prednisolone; Paroxetine hydrochloride 10 & 20 mg and prednisolone 1 mg bp; Prednisolone & dipyridamole; Prednisolone 20 mg; Prednisolone 40 mg; Prednisolone 5 mg; Prednisolone tablets bp; Prednisolone tablets usp 5 mg; Prednisolone-dipyridamole; Sulphasalazine + hydroxychloroquine or prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone; Trexan+salazopyrin+oxiklorin+prednisolone + infliximab; Z102 (prednisolone and dipyridamole).; Corticosteroids (prednisone or prednisolone); Oral prednisolone; Administration of rituximab and methylprednisolone; Prednisolone and taper; Etanercept, methotrexate, prednisolone; Methylprednisolone (mp); Prednisolone + mabthera; Corticosteroid treatment (methylprednisolone or prednisolone); Methylprednisolone or prednisolone; Methylprednisolone (mp) or prednisone (pred); Methylprednisolone mylan générique; Methylprednisolone pulse; Methylprednisolone(intravenously in the 1st-2nd-3rd month ); Methylprednisolone(intravenously in the 1st-3rd-5th month); Prednisone or prednisolone; Azd4017 and prednisolone; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Prednisolone 1mg tablets; Prednisolone 5mg tablet; Glucocorticoid (prednisone or prednisolone); Low dose prednisolone; Medium dose prednisolone; Methylprednisolone bolus iv 15 mg/kg/d for 3 days.; Corticosteroid (prednisolone); Prednisolone sodium succinate; Methylprednisolone or budesonide; Oral 5-asa+/-topical 5-asa+iv corticosteroids / po methylprednisolone; Prednisolone sodium metasulphobenzoate; Prednisolone tablets b.p. 5mg; Intravenous methylprednisolone; Pyridoxine plus prednisolone; Soluble prednisolone tablets; Intravenous (i.v.) methylprednisolone 1000 mg, total 9; Prednisolone acetate; Prednisolone and chlorambucil; Prednisolone and mycophenolate mofetil;   D00472
 D00980
 D00981
 D00982
 D01239
 D01998
 D02156
 D03301 
 1件: NR3C1   1件: Neuroactive ligand-receptor interaction   38件:
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300
 117   Prednisone  59件: Prednisone; Prednisone - azathioprine; Prednisone alone; Granulocyte-colony stimulating factor (g-csf) and prednisone; Prednisone/prednisolone; Prednisone acetate; Prednisone, cyclophosphamide; Over encapsulated prednisone; Prednisone and ustekinumab treatment; Prednisone capsules; Prednisone tablets usp, 1 mg; Prednisone tablets usp, 2.5 mg; Prednisone tablets usp, 5 mg; Prednisone tablets, usp; Prednisone therapy and pharmacokinetic; Prednisone treatment; Cyclophosphamide, azathioprine,prednisone,methylprednisolone; Prednisone, methylprednisolone,cyclophosphamides; Prednisone (and methylprednisolone); 0 mg prednisone; 5 mg prednisone; Methylprednisone; Prednisone 15 mg; Prednisone 5 mg; Prednisone 7.5 mg; Rayos (delayed-release prednisone); Corticosteroids (prednisone or prednisolone); Cyclophosphamide-prednisone-azathioprine; Oral prednisone 5mg; Prednisone discontinuation; Chinese herb prescription granule plus prednisone; Enalapril valsartan methylprednisone; Hormone (prednisone); Leflunomide 20 mg+prednisone 0.5mg/kg/d; Methylprednisolone (mp) or prednisone (pred); Mycophenolate mofetil plus lower dose of prednisone; Prednisone + inhibace/cozaar; Prednisone and cyclophosphamide; Prednisone arrow 20mg; Prednisone arrow 5 mg; Prednisone in full dose; Prednisone or prednisolone; Prednisone plus cyclophosphamide; Conventional glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone); Glucocorticoid (prednisone or prednisolone); Hydroxychloroquine + prednisone; Azathioprine/prednisone; 5-asa, prednisone, azathioprine or remicade; 5-aminosalicylic acid(5-asa) and/or prednisone; Treatment systemic therapy (prednisone); Treatment with systemic therapy (prednisone); Prednisone 0,5 mg/kg orally on alternate days; Prednisone, fk506, mmf; Tacrolimus combined with prednisone; Prednisone acetate tablets; Oral prednisone; Sotatercept with prednisone boost; Prednisone and mycophenolate mofetil; Thalidomide, cyclophosphamide and prednisone;   D00473   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   44件:
2,
11,
13,
14,
26,
35,
40,
41,
42,
43,
44,
45,
46,
49,
50,
51,
53,
61,
63,
64,
65,
66,
81,
84,
85,
86,
95,
96,
97,
113,
145,
162,
164,
222,
224,
228,
251,
283,
284,
285,
288,
299,
300,
331
 118   Prednisone acetate  2件: Prednisone acetate; Prednisone acetate tablets;   D08416   1件: NR3C1   1件: Neuroactive ligand-receptor interaction   6件:
35,
40,
41,
49,
162,
224
 119   Pyridoxine  4件: Pyridoxine; Pyridoxine 10mg; Pyridoxine 10mg bp; Pyridoxine plus prednisolone;   D02179
 D08454 
 -   -   4件:
6,
49,
93,
145
 120   Rabbit  16件: Antithymocyte immunoglobulin (rabbit); Rabbit; Rabbit human t lymphocyte immunoglobulin; Rabbit anti-thymocyte globulin; Rabbit antithymocyte globulin; Anti-human t-lymphocyte immunoglobulin from rabbits; Anti-thymocyte globulin, rabbit; Anti-thymocyte globulin (rabbit); Antithymocyte globulin (rabbit); Cyclophosphamide, fludarabine, rabbit atg; Rabbit anti-thymocyte globulin (atg); Rabbit antithymoglobulin (atg); Rabbit atg; Rabbit atg, (genzyme); Rabbit atg, cyclosporine, levamisole; Rabbit atg, thymoglobuline (genzyme);   -   -   -   7件:
13,
49,
51,
60,
65,
96,
285
 121   Ramipril  1件: Ramipril;   D00421   1件: ACE   1件: Renin-angiotensin system   7件:
46,
49,
66,
67,
113,
218,
257
 122   Riboflavin  4件: Riboflavin; Riboflavin sodium phosphate injection; Riboflavin supplementation; Cofactor supplementation (thiamine, riboflavin, l-carnitine);   D00050
 D01622
 D01913 
 -   -   9件:
13,
38,
46,
49,
96,
97,
162,
168,
265
 123   Rituximab  52件: Rituximab; Rituximab (rituxan); Mabthera (rituximab); Mabthera or biosimilar rituximab product; Rituximab infusion; Rituximab it; Rituximab iv; Combination of protein a immunoadsorption, rituximab, dexamethasone plus azathioprine; Rituximab (mabthera® or rituxan®).; Rituximab and cyclophosphamide iv; Rituximab (arm a); Rituximab (arm b); Abatacept, rituximab or tocilizumab; Abp 798 - biosimilar to rituximab; Gp2013 - a proposed biosimilar rituximab; Idec-c2b8 (rituximab); Mabthera® (rituximab); Originator rituximab - rituxan ® or mabthera ®; Rituxan (inn: rituximab), brand name in the united states; Rituxan® (rituximab); Rituximab - mabthera; Rituximab [mabthera/rituxan]; Rituximab [mabthera]; Rituximab mabthera; Rituximab, mtx, folic acid; Rituximab, observational study amon patients with active ra; Rituximab-eu+ rituximab-pfizer x 2 courses; Rituximab-pfizer (pf-05280586) x 3 courses; Rituximab-us + rituximab-pfizer x 2 courses; Sait101 (proposed rituximab biosimilar); Individualized dose of rituximab; Rituxan (rituximab); Standard dose of rituximab; Administration of rituximab and methylprednisolone; Rituximab (anti-cd20); Alemtuzumab and rituximab; Bendamustine, rituximab; Mabthera or biosimilar rituximab; Rituximab (mabthera®); Alemtuzumab, rituximab; Dexamethasone and rituximab; Rhtpo in combination with rituximab; Immunosuppressive treatment (eg, rituximab); Rituximab (rtx) and azathioprine (aza); Intravenous rituximab; Combined plasma exchange (pex), rituximab, and corticosteroids; The standard steroid treatment, plasma exchange and rituximab; Rituximab 1g iv; Rituximab combined with omalizumab; Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab); Rituximab/ mabthera; Rituximab or rituximab hyaluronidase human;   D02994   1件: MS4A1   1件: Hematopoietic cell lineage   42件:
11,
13,
14,
17,
35,
36,
43,
44,
45,
46,
49,
50,
51,
52,
53,
56,
60,
61,
63,
64,
65,
66,
83,
84,
85,
86,
93,
94,
96,
97,
162,
222,
223,
229,
256,
271,
283,
284,
285,
288,
300,
331
 124   Rivaroxaban  1件: Rivaroxaban;   D07086   1件: F10   1件: Complement and coagulation cascades   2件:
46,
49
 125   Rontalizumab  1件: Rontalizumab;   D09662   -   -   1件:
49
 126   Rosuvastatin  6件: Rosuvastatin; Rosuvastatin calcium; Calcium rosuvastatin; Crestor tablets (calcium rosuvastatin) film-coated tablets; Rosuvastatin 20mg; Rosuvastatin 10 mg;   D01915
 D08492 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   8件:
6,
46,
49,
51,
79,
96,
271,
299
 127   Royal jelly  1件: Royal jelly;   D09754   -   -   1件:
49
 128   Salbutamol  5件: Salbutamol; Salbutamol 4mg tablet; R-salbutamol; R-salbutamol sulphate; Nebulized combination ipratropium bromide with salbutamol;   D02147   1件: ADRB2   3件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, cAMP signaling pathway   13件:
3,
11,
12,
13,
49,
85,
86,
89,
113,
228,
231,
256,
299
 129   Sifalimumab  4件: Sifalimumab; Sifalimumab 1,200 mg; Sifalimumab 200 mg; Sifalimumab 600 mg;   D09668   -   -   1件:
49
 130   Simvastatin  16件: Simvastatin; Simvastatine; Encapsulated simvastatin tablets; Simvastatin 40 mg film-coated tablets; Simvastatin alternova; Simvastatina; Simvastatina sandoz 40 mg comprimidos recubiertos con película efg; Simvastatine sandoz 40 mg filmomhulde tabletten; Simvastatine sandoz 40mg deelbare filmomhulde tabletten; Simvastatin 20mg/5ml oral suspension; Ezetimibe+simvastatin drug combination; Simvastatin 40mg; Simvastatin-ratiopharm; Simvastatin-ratiopharm®; Simvastatin treatment for 28 days; Simvastatin susp.;   D00434   1件: HMGCR   1件: Terpenoid backbone biosynthesis   19件:
6,
13,
15,
34,
46,
49,
51,
66,
79,
86,
89,
94,
158,
162,
195,
265,
298,
299,
310
 131   Sirolimus  16件: Sirolimus; Temsirolimus; Temsirolimus tablets; Sirolimus 2 mg; Skincerity plus sirolimus/rapamycin; Skinercity plus sirolimus/rapamycin; Sirolimus (formerly known as rapamycin); Sirolimus 2%; Sirolimus, 2%; Rapamycin, sirolimus; Sirolimus and hydroxychloroquine; Sirolimus 0.2%; Sirolimus 0.4%; Sirolimus 0,1% crème; Sirolimus oral liquid product 1mg/ml; Topical 0.1% sirolimus;   D00753   1件: MTOR   2件: Pathways in cancer, mTOR signaling pathway   36件:
2,
13,
15,
17,
34,
35,
36,
46,
49,
51,
60,
61,
62,
63,
65,
66,
67,
85,
86,
89,
96,
98,
137,
157,
158,
192,
222,
256,
277,
278,
279,
280,
281,
283,
285,
331
 132   Sulfamethoxazole  6件: Sulfamethoxazole; Trimethoprim sulfamethoxazole; Trimethoprim-sulfamethoxazole; Trimethoprim sulfamethoxazole (tmp/smx); Trimethoprim/sulfamethoxazole; Trimethoprim/sulfamethoxazole (tmp/smx);   D00447   -   -   4件:
44,
49,
85,
299
 133   Sulfate ion  0件:   -   -   -   22件:
2,
6,
11,
13,
26,
34,
36,
46,
49,
60,
61,
64,
66,
79,
86,
96,
222,
226,
265,
296,
297,
299
 134   TRU-015  1件: Tru-015;   -   -   -   3件:
46,
49,
222
 135   Tabalumab  4件: Ly2127399 (tabalumab); Tabalumab; Tabalumab auto-injector; Tabalumab prefilled syringe;   D10083   1件: TNFSF13B   1件: Cytokine-cytokine receptor interaction   2件:
46,
49
 136   Tacrolimus  13件: Tacrolimus; Tacrolimus capsule; Interferon beta-1b and tacrolimus; Non-mtx dmards (e.g. sulfasalazine, leflunomide, bucillamine, tacrolimus, or mizoribin); Tacrolimus (prograf®); Tacrolimus with methotrexate; Busulfan/fludarabine phosphate/tacrolimus/methotrexate/g-csf; Lcp-tacro (tacrolimus); Rectal tacrolimus; Tacrolimus capsules; Tacrolimus combined with prednisone; Tacrolimus and mmf; Tacrolimus prolonged-release hard capsules;   D00107
 D08556 
 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   30件:
2,
11,
13,
36,
46,
49,
50,
51,
53,
60,
61,
62,
65,
66,
85,
86,
95,
96,
97,
113,
151,
158,
164,
222,
224,
226,
228,
283,
284,
299
 137   Thalidomide  9件: Thalidomide; Thalidomide (drug); Fpf 300 (thalidomide); Melphalan, thalidomide and dexamethasone; Thalidomide pharmion; Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule; Thalidomide 100mg; Thalidomide 150mg; Thalidomide, cyclophosphamide and prednisone;   D00754   1件: TNF   4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, NF-kappa B signaling pathway, TNF signaling pathway   18件:
2,
16,
20,
28,
49,
51,